This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khoschsorur, G.
Right arrow Articles by Zelzer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khoschsorur, G.
Right arrow Articles by Zelzer, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2005, p. 3569-3571, Vol. 49, No. 8
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.8.3569-3571.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Isocratic High-Performance Liquid Chromatographic Method with Ultraviolet Detection for Simultaneous Determination of Levels of Voriconazole and Itraconazole and Its Hydroxy Metabolite in Human Serum

GholamAli Khoschsorur,* Franz Fruehwirth, and Sieglinde Zelzer

Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria

Received 2 March 2005/ Returned for modification 21 March 2005/ Accepted 20 May 2005

A simple, specific method is presented for simultaneous determination of voriconazole and itraconazole and its metabolite, hydroxyitraconazole, in human serum using one-step liquid-liquid extraction and high-performance liquid chromatography. Linearity tests ranged from 0.1 to 8.0 µg/ml; the minimum detectable concentration was 0.03 µg/ml.


* Corresponding author. Mailing address: Institute of Medical and Chemical Laboratory Diagnostics (LB.I), Auenbruggerplatz 29, A-8036 Graz, Austria. Phone: 316-385-2296. Fax: 316-385-3419. E-mail: g.Khoschsorur{at}klinikum-graz.at.


Antimicrobial Agents and Chemotherapy, August 2005, p. 3569-3571, Vol. 49, No. 8
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.8.3569-3571.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kahle, K., Langmann, P., Schirmer, D., Lenker, U., Keller, D., Helle, A., Klinker, H., Heinz, W. J. (2009). Simultaneous Determination of Voriconazole and Posaconazole Concentrations in Human Plasma by High-Performance Liquid Chromatography. Antimicrob. Agents Chemother. 53: 3140-3142 [Abstract] [Full Text]  
  • Joukhadar, C., Thallinger, C., Poppl, W., Kovar, F., Konz, K. H., Joukhadar, S. M., Traunmuller, F. (2009). Concentrations of Voriconazole in Healthy and Inflamed Lung in Rats. Antimicrob. Agents Chemother. 53: 2684-2686 [Abstract] [Full Text]  
  • Spriet, I., Annaert, P., Meersseman, P., Hermans, G., Meersseman, W., Verbesselt, R., Willems, L. (2009). Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. J Antimicrob Chemother 63: 767-770 [Abstract] [Full Text]  
  • Weiler, S., Zoller, H., Graziadei, I., Vogel, W., Bellmann-Weiler, R., Joannidis, M., Bellmann, R. (2007). Altered Pharmacokinetics of Voriconazole in a Patient with Liver Cirrhosis. Antimicrob. Agents Chemother. 51: 3459-3460 [Full Text]